Atrial fibrillation (AF) is the most common sustained arrhythmia,
affecting approximately 2.3 million people in the US. One of the
most serious side effects of AF is embolic stroke. Technology
developed in the last 10 years has made AF treatable and
potentially curable. This issue discusses many of the clinical
issues in the management of AF, including cardioversion,
anticoagulation, and ablation. Also included are current guidelines
for treatment and a view of the future.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!